Biological E’s Corbevax safe and immunogenic in five to 18 age group
The phase-II/III clinical trial results have been published in peer-reviewed and international journal 'Vaccine'
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.